FDA issues a guidance with recommendations for blood collection establishments on using serological tests to reduce the risk of transmission of human ...
Federal Register notice: FDA announces a 3/11 Nonprescription Drugs Advisory Committee meeting on food handler antiseptic drug products.
Federal Register notice: FDA makes available a draft guidance entitled Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Developing Drugs for Trea...
A Medscape commentary column recommends that FDA prevent drug companies from covering expenses for any public individuals who testify at an advisory c...
Federal Register notice: FDA announces a 4/22 public meeting on Prescription Drug User Fee Act of 2017; Electronic Submissions and Data Standards.
FDA releases the FDA-483 with five observations from an inspection at the Lupin facility in Andhra, Pradesh, India.
FDA warns consumers and healthcare professionals about the significant safety risks associated with using dietary supplements containing cesium salts.
FDA warns Marco Pharma about CGMP and misbranding violations in its production of dietary supplements.